Supreme Court Upholds Conviction as Husband Failed to Explain Wife’s Death in Matrimonial Home || Supreme Court: Crime Scene Re-Enactment Does Not Always Violate Right Against Self-Incrimination || Supreme Court: Cognizance Taken Without Hearing Accused under BNSS Section 223 is Void Ab Initio || Supreme Court Upholds Will in Sister’s Favour, Says Excluding Natural Heirs is Not Suspicious || Delhi HC: Absence of Public Witnesses and Videography in NDPS Recovery Relevant for Bail Decisions || Raj HC Initiates Suo Motu Cognizance Over Severe Water Crisis in Jodhpur, Issues Interim Directions || Del HC: Courts Cannot Direct, Monitor Inquiry Into Police Delay in Investigation After Bail Decision || Supreme Court: After the BNSS, a Pre-Cognizance Hearing is Mandatory in PMLA Cases || SC: Landowners Cannot be Forced to Waive Statutory Compensation to Claim Other Benefits || Supreme Court: Banks are Lenient With Big Borrowers But Strict With Ordinary Loan Applicants

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :